Matthew S. Ning, MD, MPH
Department of Thoracic Radiation Oncology, Division of Radiation Oncology
Present Title & Affiliation
Primary Appointment
Patient Experience Officer, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Education Director (Department level), Department of Thoracic Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Director of Clinical Value, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Assistant Professor, Department of Thoracic Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Assistant Professor, Department of Thoracic Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2019 | The University of Texas Health Science Center, Houston, Texas, US, MPH in Healthcare Management |
| 2015 | Vanderbilt University School of Medicine, Nashville, Tennessee, US, Doctorate of Medicine, MD |
| 2011 | Virginia Polytechnic Institute and State University, Blacksburg, Virginia, US, BS in Biochemistry |
Postgraduate Training
| 2016-2020 | Clinical Residency, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2015-2016 | Clinical Internship, Internal Medicine, MedStar Washington Hospital Center, Washington, DC |
Board Certifications
| 2021 | American Board of Radiology (ABR) |
Experience & Service
Administrative Appointments/Responsibilities
Patient Experience Officer, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2023 - Present
Resident Education Director, Department of Thoracic Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2022 - Present
Director of Clinical Value, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - Present
Institutional Committee Activities
Moderator, Esophageal Multidisciplinary Tumor Board Conference, 2024 - Present
Selected Member, ASTRO Code Utilization and Application Committee, 2023 - Present
Selected Member, ASTRO Payor Relations Committee, 2023 - Present
Clinical Co-Lead, PTC2/Proton Disease Site Transition & Development: Thoracic Working Group, 2023 - Present
Elected Representative, Institutional Faculty Senate, 2022 - Present
Lead, Rad Onc Insurance Workflow Automation Working Group, 2022 - Present
Member, Radiation Oncology Finance Committee, 2022 - Present
Elected Representative, PRS Clinical Revenue Cycle Committee, 2021 - Present
Rad Onc Back-Up AMD, Thoracic Center Multidisciplinary Leadership Team, 2020 - 2021
Co-Lead, Radiation Oncology Operational Tier System Working Group, 2020 - 2021
Lead, Radiation Oncology Clin Ops: Billing & Reimbursement Working Group, 2020 - Present
Member, Radiation Oncology Cancer Network Research Steering Committee, 2020 - Present
Data Analyst, Radiation Oncology COVID-19 Tracer Team, 2020 - 2020
Member, Radiation Oncology Alternative Payment Model (APM) Working Group, 2020 - 2021
Clinical Co-Lead, Proton Therapy Center Health Economics Committee, 2019 - Present
Member, Radiation Oncology Quality & Safety Committee, 2017 - 2020
Honors & Awards
| Phi Beta Kappa Academic Society, Virginia Tech | |
| Outstanding Graduating Senior of the College of Science, Virginia Tech | |
| VMS Williams Tuition Scholarship, Vanderbilt University School of Medicine | |
| VICTR Translational Pilot Funding, Vanderbilt Institute for Clinical and Translational Research | |
| Meharry/VICC/TSU Cancer Partnership Grant, Meharry/VICC/TSU Cancer Partnership | |
| ASA Student Grant Targeting Melanoma and Skin Cancer, American Skin Association | |
| Best of ASTRO, American Society for Radiation Oncology | |
| RSNA Research Resident Grant, Radiological Society of North America | |
| Lean Six Sigma Yellow Belt Certification, UT Health | |
| ABS Prostate and GYN School Scholarship, American Brachytherapy Society | |
| Thomas H. & Mayme P. Scott Cancer Research Fellowship, UT MDACC | |
| Delta Omega Honorary Society, UT Health | |
| Bristol-Myers Squibb Population Science Competition Finalist, UT MDACC | |
| ASRT Invited Faculty Travel Grant, American Society of Radiologic Technologists | |
| Lean Bronze Certification, UT MDACC Quality College | |
| ROC-STaR Award (x2): Radiation Oncology Commendations and Recognition, UT MDACC | |
| James D. Cox Award for Research Excellence, Gilbert H. Fletcher Society | |
| Diagnostic Imaging Celebrate Solutions: Clinical Quality Project Winner (2nd Place), UT MDACC | |
| Awesome Job Award (for Excellent Patient Care), UT MDACC | |
| ROC-STaR Award: Radiation Oncology Commendations and Recognition, UT MDACC | |
| Top 1% Care Provider: Patient Experience & Satisfaction, CG-CAHPS (Press Ganey) | |
| Awesome Job Award (for Administrative Leadership), UT MDACC | |
| Luis Delclos Excellence in Teaching Award, MDACC Rad Onc Residency Class of 2024 |
Selected Publications
Peer-Reviewed Articles
- Salazar, RM, Nair, SS, Leone, A, Xu, T, Mumme, R, Duryea, J, De, BS, Corrigan, KL, Rooney, MK, Ning, M, Das, P, Holliday, EB, Liao, Z, Court, LE, Niedzielski, JS. Performance Comparison of 10 State-of-the-Art Machine Learning Algorithms for Outcome Prediction Modeling of Radiation-Induced Toxicity. Advances in Radiation Oncology 10(2), 2025. PMID: 39717195.
- Cabanillas, ME, Dadu, R, Ferrarotto, R, Gule-Monroe, MK, Liu, S, Fellman, B, Williams, MD, Zafereo, M, Wang, RJ, Lu, C, Ning, M, McKinley, BA, Woodman, SE, Duose, D, Gunn, GB, Busaidy, NL. Anti-Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma. JAMA Oncology 10(12):1672-1680, 2024. PMID: 39446377.
- Amini, A, Zaha, VG, Hamad, E, Woodard, PK, Rimner, A, Chang, JY, Chun, SG, Donington, J, Edelman, MJ, Gubens, M, Higgins, K, Iyengar, P, Juloori, A, Movsas, B, Ning, M, Park, HS, Rodrigues, GB, Wolf, A, Simone, C. American Radium Society Appropriate Use Criteria on Cardiac Toxicity Prevention and Management After Thoracic Radiotherapy. Journal of Thoracic Oncology 19(12):1654-1667, 2024. PMID: 39313150.
- Park, HS, Rimner, A, Amini, A, Chang, JY, Chun, SG, Donington, J, Edelman, MJ, Gubens, M, Higgins, K, Iyengar, P, Juloori, A, Movsas, B, Nemeth, Z, Ning, M, Rodrigues, GB, Wolf, A, Simone, C. Appropriate Use Criteria (AUC) for the Management of Non-Small Cell Lung Cancer in a Central/Ultra-Central Location. Journal of Thoracic Oncology 19(12):1640-1653, 2024. PMID: 39271016.
- Ning, M, Odwuor, A, Chang, JY, Gandhi, S, Liao, Z, Lin, SH, Chen, A, Welsh, J, Nguyen, Q, O'Reilly, M, Chun, SG, Bronk, JK, Qian, DC, Lee, PP. Salvage Reirradiation with Proton Beam Therapy for Locoregionally Recurrent Non-Small Cell Lung Cancer. Cancers 16(21), 2024. PMID: None.
- Wang, L, Ding, Y, Bruno, TL, Stafford, RJ, Lin, E, Bathala, TK, Sanders, JW, Ning, M, Ma, J, Klopp, AH, Venkatesan, AM, Wang, J, Martirosyan, KS, Frank, SJ. A Novel Positive-Contrast Magnetic Resonance Imaging Line Marker for High-Dose-Rate (HDR) MRI-Assisted Radiosurgery (MARS). Cancers 16(10), 2024. PMID: 38792000.
- Rodrigues G, Higgins KA, Rimner A, Amini A, Chang JY, Chun SG, Donington J, Edelman MJ, Gubens MA, Iyengar P, Movsas B, Ning MS, Park HS, Wolf A, Simone CB 2nd. American Radium Society Appropriate Use Criteria for Unresectable Locally Advanced Non-Small Cell Lung Cancer. JAMA Oncol None(None):None, 2024. PMID: 38602670.
- Corrigan KL, Xu T, Sasaki Y, Lin R, Chen AB, Welsh JW, Lin SH, Chang JY, Ning MS, Gandhi S, O'Reilly MS, Gay CM, Altan M, Lu C, Cascone T, Koutroumpakis E, Sheshadri A, Zhang X, Liao L, Zhu XR, Heymach JV, Nguyen QN, Liao Z. Survival outcomes and toxicity of adjuvant immunotherapy after definitive concurrent chemotherapy with proton beam radiation therapy for patients with inoperable locally advanced non-small cell lung carcinoma. Radiother Oncol 193(None):110121, 2024. PMID: 38311031.
- Weng J, Mesko S, Chronowski G, Lee P, Choi S, Das P, Koong AC, French K, Aloia T, Ehlers R, Elrod-Joplin D, Kerr A, Smith R, Martinez W, Bloom E, Shah SJ, Ning MS, Liao Z, Herman J, Moningi S, Moreno AC, Nguyen QN. Optimizing Outpatient Radiation Oncology Consult Workflow by Using Time-Driven Activity-Based Costing: Efficiency and Financial Impacts. JCO Oncol Pract None(None):OP2300037, 2024. PMID: 38330252.
- Ludmir EB, Hoffman KE, Jhingran A, Kouzy R, Ip MP, Sturdevant L, Ning MS, Minsky BD, McAleer MF, Chronowski GM, Arzu IY, Reed VK, Garg AK, Roberts T, Eastwick GA, Olson MR, Selek U, Gabel M, Koong AC, Kupferman ME, Kuban DA. Implementation and Efficacy of a Large-Scale Radiation Oncology Case-Based Peer-Review Quality Program across a Multinational Cancer Network. Pract Radiat Oncol 14(3):e173-e179, 2024. PMID: 38176466.
- Brooks, ED, Giap, F, Cassidy, V, Ning, M, Robbert, B, Redding, P, Palmer, MB, Turner, L, Mendenhall, WM, Klein, S, Mendenhall, N. Strategic Operational Redesign Improves Prior Authorization Access. International Journal of Particle Therapy 10(2):65-72, 2023. PMID: 38075483.
- Grover S, Lichter KE, Likhacheva A, Jang JW, Ning MS, Robin TP, Small W, Kudchadker RJ, Swamidas J, Chopra S, Rai B, Sharma SD, Sharma DN, Kuppusamy T, Yang R, Berger D, Mendez LC, Glaser S, Erickson DL, Chino J, Mourtada F, Abdel-Wahab M, Jhingran A, Simonds H, Mahantshetty U. The American Brachytherapy Society and Indian Brachytherapy Society consensus statement for the establishment of high-dose-rate brachytherapy programs for gynecological malignancies in low- and middle-income countries. Brachytherapy 22(6):716-727, 2023. e-Pub 2023. PMID: 37704540.
- Jacobsen MC, Rigaud B, Simiele SJ, Rauch GM, Ning MS, Vedam S, Klopp AH, Stafford RJ, Brock KK, Venkatesan AM. Feasibility of quantitative diffusion-weighted imaging during intra-procedural MRI-guided brachytherapy of locally advanced cervical and vaginal cancers. Brachytherapy 22(6):736-745, 2023. e-Pub 2023. PMID: 37612174.
- Chun SG, Rimner A, Amini A, Chang JY, Donington J, Edelman MJ, Geng Y, Gubens MA, Higgins KA, Iyengar P, Movsas B, Ning MS, Park HS, Rodrigues G, Wolf A, Simone CB. American Radium Society Appropriate Use Criteria for Radiation Therapy in the Multidisciplinary Management of Thymic Carcinoma. JAMA Oncol 9(7):971-980, 2023. e-Pub 2023. PMID: 37186595.
- Li B, Hirata E, Trejo JM, Garcia B, Chang B, Malhotra S, Ning M, Sarria GJ. Exploring the Cost of Radiation Therapy Delivery for Locally Advanced Cervical Cancer in a Public and a Private Center in Latin America Using Time-Driven Activity-Based Costing. Int J Radiat Oncol Biol Phys 115(5):1205-1216, 2023. PMID: 36922083.
- De B, Farooqi AS, Mitchell KG, Ludmir EB, Lewis J, Rinsurongkawong W, Rinsurongkawong V, Lee JJ, Swisher SG, Gibbons DL, Zhang J, Le X, Elamin YY, Gomez DR, Ning MS, Lin SH, Liao Z, Chang JY, Vaporciyan AA, Heymach JV, Antonoff MB, Gandhi SJ. Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non-Small-Cell Lung Cancer Reveals EGFR Mutations to Be Associated With Longer Overall Survival. JCO Precis Oncol 7:e2200540, 2023. PMID: 36716413.
- Liu Y, Zhang Z, Rinsurongkawong W, Gay CM, Le X, Ning MS, Lewis J, Rinsurongkawong V, Lee JJ, Roth J, Swisher S, Gandhi S, Lee PP, Gibbons DL, Vaporciyan AA, Heymach JV, Zhang J, Lin SH. Association of Driver Oncogene Variations With Outcomes in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Chemoradiation and Consolidative Durvalumab. JAMA Netw Open 5(6):e2215589, 2022. e-Pub 2022. PMID: 35666500.
- McGinnis GJ, Ning MS, Beadle BM, Joubert N, Shaw W, Trauernich C, Simonds H, Grover S, Cardenas CE, Court LE, Smith GL. Barriers and Facilitators of Implementing Automated Radiotherapy Planning: A Multisite Survey of Low- and Middle-Income Country Radiation Oncology Providers. JCO Glob Oncol 8:e2100431, 2022. PMID: 35537104.
- Gjyshi O, Lin SH, Pezzi TA, Ning MS, Ma J, Liu S, Rusthoven CG. Care Patterns for Stereotactic Radiosurgery in Small Cell Lung Cancer Brain Metastases. Clin Lung Cancer 23(2):185-190, 2022. e-Pub 2021. PMID: 34419375.
- De Leo AN, Dagan R, Amdur RJ, Yeung AR, Li J, Brooks ED, Gilbo P, Gomez D, Chang JY, Ning M. How Three Academic Centers Prescribe SBRT for Primary Lung Cancer. Pract Radiat Oncol 12(6):496-503, 2022. e-Pub 2022. PMID: 35219881.
- Brooks ED, Wang X, De B, Verma V, Williamson TD, Hunter R, Mohamed ASR, Ning MS, Zhang X, Chang JY. An algorithm for thoracic re-irradiation using biologically effective dose: a common language on how to treat in a "no-treat zone". Radiat Oncol 17(1):4, 2022. e-Pub 2022. PMID: 34991637.
- Boyce-Fappiano D, Ning MS, Gjyshi O, Mesko S, Pasalic D, Chang AJ, Orio PF, Thaker NG. Payment Methodology for the Radiation Oncology Alternative Payment Model: Implications for Practices and Suggestions for Improvement. JCO Oncol Pract 17(12):OP2100200, 2021. e-Pub 2021. PMID: 34097458.
- Ning MS, Boyce-Fappiano D, Thaker NG. Oligometastatic Disease in Context of the Radiation Oncology Alternative Payment Model: Implications for Local Consolidative Therapy. JCO Oncol Pract 17(12):OP2100549, 2021. e-Pub 2021. PMID: 34767465.
- Chang, JY, Mehran, RJ, Feng, L, Verma, V, Liao, Z, Welsh, J, Lin, SH, O'Reilly, M, Jeter, M, Balter, PA, McRae, SE, Berry, D, Heymach, JV, Roth, JA, Antonoff, MB, Hofstetter, WL, Rajaram, R, Rice, DC, Sepesi, B, Swisher, SG, Vaporciyan, AA, Walsh, GL, DeGraaf, C, Correa, AM, Chen, A, Gandhi, S, Komaki, R, Lee, PP, Nguyen, Q, Ning, M, Gao, S, Pollard-Larkin, JM, Nitsch, PL, Sadagopan, R, Wang, X. Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS). The lancet oncology 22(10):1448-1457, 2021. PMID: 34529930.
- Patel RR, He K, Barsoumian HB, Chang JY, Tang C, Verma V, Comeaux N, Chun SG, Gandhi S, Truong MT, Erasmus JJ, Hong DS, Lee PP, Ning MS, Nguyen QN, Heymach JV, Altan M, Blumenschein G, Fossella FV, Sezen D, Chen D, Carter BW, Davies MA, Glitza IC, Diab A, Ferrarotto R, Cabanillas ME, Yuan Y, Shah SJ, Parra ER, Sun B, Cortez MA, Welsh JW. High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial. Radiother Oncol 162:60-67, 2021. e-Pub 2021. PMID: 34237343.
- Grover S, Ning MS, Bale M, Lichter KE, Shah S, Bvochora-Nsingo M, Chiyapo S, Balang D, McGinnis GJ, Ralefala T, Moloi T, Luckett R, Ramogola-Masire D, Robertson ES, Zetola NM. Chemoradiation versus radiation alone in stage IIIB cervical cancer patients with or without human immunodeficiency virus. Int J Gynecol Cancer 31(9):1220-1227, 2021. e-Pub 2021. PMID: 34312220.
- Sapienza LG, Ning MS, Carvalho EF, Spratt D, Calsavara VF, McLaughlin PW, Gomes MJL, Baiocchi G, Abu-Isa E. Efficacy and Incontinence Rates After Urethroplasty for Radiation-Induced Urethral Stenosis: A Systematic Review and Meta-Analysis. Urology 152:109-116, 2021. e-Pub 2021. PMID: 33631205.
- McGinnis GJ, Ning MS, Bvochora-Nsingo M, Chiyapo S, Balang D, Ralefala T, Lin A, Zetola NM, Grover S. Management of Head and Neck Cancers With or Without Comorbid HIV Infection in Botswana. Laryngoscope 131(5):E1558-E1566, 2021. e-Pub 2020. PMID: 33098322.
- Yeboa DN, Akinfenwa CA, Nguyen J, Amaya D, de Gracia B, Ning M, Cox V, De B, Smith BD, Lin L, Beddar S, Hoang H, Koong A, Liao Z. Effectively Conducting Oncology Clinical Trials During the COVID-19 Pandemic. Adv Radiat Oncol 6(3):100676, 2021. e-Pub 2021. PMID: 33686374.
- Chapman BV, Ning MS, Farnia B, Mesko S, Lin SH, Tang C, Allen PK, Liao Z, Chang JY, Komaki R, Mehran RJ, Gandhi SJ, Gomez DR. Postoperative Radiotherapy for Locally Advanced NSCLC: Implications for Shifting to Conformal, High-Risk Fields. Clin Lung Cancer 22(3):225-233.e7, 2021. e-Pub 2020. PMID: 32727706.
- Ning MS, Das P, Rosenthal DI, Dabaja BS, Liao Z, Chang JY, Gomez DR, Klopp AH, Gunn GB, Allen PK, Nitsch PL, Natter RB, Briere TM, Herman JM, Wells R, Koong AC, McAleer MF. Early and Midtreatment Mortality in Palliative Radiotherapy: Emphasizing Patient Selection in High-Quality End-of-Life Care. J Natl Compr Canc Netw 19(7):1-9, 2021. e-Pub 2021. PMID: 33878727.
- Bishop AJ, Livingston JA, Ning MS, Valdez ID, Wages CA, McAleer MF, Paulino AC, Grosshans DR, Woodhouse KD, Tao R, Roth ME, Gunn GB, McGovern SL. Young Adult Populations Face yet another Barrier to Care with Insurers: Limited Access to Proton Therapy. Int J Radiat Oncol Biol Phys 110(5):1496-1504, 2021. e-Pub 2021. PMID: 33677051.
- Huang D, Frank SJ, Verma V, Thaker NG, Brooks ED, Palmer MB, Harrison RF, Deshmukh AA, Ning MS. Cost-Effectiveness Models of Proton Therapy for Head and Neck: Evaluating Quality and Methods to Date. Int J Part Ther 8(1):339-353, 2021. e-Pub 2021. PMID: 34285960.
- Smith GL, Fu S, Ning MS, Nguyen DK, Busse PM, Foote RL, Garden AS, Gunn GB, Fuller CD, Morrison WH, Chronowski GM, Shah SJ, Mayo LL, Phan J, Reddy JP, Snider JW, Patel SH, Katz SR, Lin A, Mohammed N, Dagan R, Lee NY, Rosenthal DI, Frank SJ. Work Outcomes after Intensity-Modulated Proton Therapy (IMPT) versus Intensity-Modulated Photon Therapy (IMRT) for Oropharyngeal Cancer. Int J Part Ther 8(1):319-327, 2021. e-Pub 2021. PMID: 34285958.
- Thaker NG, Boyce-Fappiano D, Ning MS, Pasalic D, Guzman A, Smith G, Holliday EB, Incalcaterra J, Garden AS, Shaitelman SF, Gunn GB, Fuller CD, Blanchard P, Feeley TW, Kaplan RS, Frank SJ. Activity-Based Costing of Intensity-Modulated Proton versus Photon Therapy for Oropharyngeal Cancer. Int J Part Ther 8(1):374-382, 2021. e-Pub 2021. PMID: 34285963.
- Maroongroge S, Smith B, Bloom ES, Ning MS, Wang C, Das P, Koong AC, McAleer MF, Woodhouse KD. Telemedicine for Radiation Oncology in a Post-COVID World. Int J Radiat Oncol Biol Phys 108(2):407-410, 2020. PMID: 32890522.
- Sims TT, Biegert GWG, Ramogola-Masire D, Ngoni K, Solley T, Ning MS, El Alam MB, Mezzari M, Petrosino J, Zetola NM, Schmeler KM, Colbert LE, Klopp AH, Grover S. Tumor microbial diversity and compositional differences among women in Botswana with high-grade cervical dysplasia and cervical cancer. Int J Gynecol Cancer None(None):None, 2020. e-Pub 2020. PMID: 32675252.
- Brooks ED, Ning MS, Palmer MB, Gunn GB, Frank SJ, Shah AK. Strategic Operational Redesign for Successfully Navigating Prior Authorization Barriers at a Large-Volume Proton Therapy Center. JCO Oncol Pract None(None):JOP1900533, 2020. e-Pub 2020. PMID: 32639929.
- Ning MS, Venkatesan AM, Stafford RJ, Bui TP, Carlson R, Bailard NS, Vedam S, Davis R, Olivieri ND, Guzman AB, Incalcaterra JR, McKelvey FA, Thaker NG, Rauch GM, Tang C, Frank SJ, Joyner MM, Lin LL, Jhingran A, Eifel PJ, Klopp AH. Developing an intraoperative 3T MRI-guided brachytherapy program within a diagnostic imaging suite: Methods, process workflow, and value-based analysis. Brachytherapy 19(4):427-437, 2020. e-Pub 2019. PMID: 31786169.
- Noticewala SS, Koong AC, Bloom ES, Choi S, Chronowski G, Ghafar RA, Guadagnolo BA, Gunn GB, Klopp A, Lee P, Li J, Liao Z, Ludmir EB, McAleer MF, Nguyen QN, Ning MS, Robinson IJ, Rosenthal DI, Shah SJ, Woodward WA, Zaebst DJ, Dabaja BS, Das P. Radiation Oncology Strategies to Flatten the Curve During the Coronavirus Disease 2019 (COVID-19) Pandemic: Experience From a Large Tertiary Cancer Center. Adv Radiat Oncol 5(4):567-572, 2020. e-Pub 2020. PMID: 32775771.
- Pezzi TA, Ning MS, Thaker NG, Boyce-Fappiano D, Gjyshi O, Olivieri ND, Guzman AB, Incalcaterra JR, Mesko S, Gandhi S, Chun S, Tang C, Frank SJ, Gomez DR. Evaluating single-institution resource costs of consolidative radiotherapy for oligometastatic non-small cell lung cancer using time-driven activity-based costing. Clin Transl Radiat Oncol 23:80-84, 2020. e-Pub 2020. PMID: 32529054.
- Ayoub Z, Ning MS, Brooks ED, Kang J, Welsh JW, Chen A, Gandhi S, Heymach JV, Vaporciyan AA, Chang JY. Definitive Management of Presumed Synchronous Early Stage Non-Small Cell Lung Cancers: Outcomes and Utility of Stereotactic Ablative Radiation Therapy. Int J Radiat Oncol Biol Phys 107(2):261-269, 2020. e-Pub 2020. PMID: 32044413.
- Sapienza LG, Ning MS, de la Pena R, McNew LK, Jhingran A, Georgeon L, Rasool N, Gomes MJL, Abu-Isa E, Baiocchi G. Outcomes and toxicity after salvage radiotherapy for vaginal relapse of endometrial cancer. Int J Gynecol Cancer None(None):None, 2020. e-Pub 2020. PMID: 32376738.
- Ning MS, Vedam S, Ma J, Stafford RJ, Bruno TL, Cunningham M, Starks C, Lawyer A, Venkatesan AM, Wang L, Wang J, Olivieri ND, Guzman AB, Incalcaterra JR, Thaker NG, Joyner MM, Lin LL, Jhingran A, Eifel PJ, Klopp AH. Clinical utility and value contribution of an MRI-positive line marker for image-guided brachytherapy in gynecologic malignancies. Brachytherapy 19(3):305-315, 2020. e-Pub 2020. PMID: 32265119.
- Ning MS, McAleer MF, Jeter MD, Minsky BD, Ghafar RA, Robinson IJ, Nitsch PL, Zaebst DJ, Todd SE, Nguyen J, Lin SH, Liao Z, Lee P, Gunn GB, Klopp AH, Dabaja BS, Nguyen QN, Chronowski GM, Bloom ES, Koong AC, Das P. Mitigating the impact of COVID-19 on oncology: Clinical and operational lessons from a prospective radiation oncology cohort tested for COVID-19. Radiother Oncol 148(None):252-257, 2020. e-Pub 2020. PMID: 32474129.
- Ning MS, Palmer MB, Shah AK, Chambers LC, Garlock LB, Melson BB, Frank SJ. Three-Year Results of a Prospective Statewide Insurance Coverage Pilot for Proton Therapy: Stakeholder Collaboration Improves Patient Access to Care. JCO Oncol Pract None(None):JOP1900437, 2020. e-Pub 2020. PMID: 32302271.
- Mesko S, Ning MS, Lakomy D, Verma V, Chang JY, O'Reilly M, Jeter MD, Gandhi SJ, Lin SH, Nguyen QN, Liao Z, Welsh J, Chen AB, Hahn S, Gomez DR. Thoracic radiation oncology clinical trial accrual and reasons for non-enrollment: results of a large, prospective, multi-year analysis. Int J Radiat Oncol Biol Phys None(None):None, 2020. e-Pub 2020. PMID: 32360653.
- Boyce-Fappiano D, Ning MS, Thaker NG, Pezzi TA, Gjyshi O, Mesko S, Anakwenze C, Olivieri ND, Guzman AB, Incalcaterra JR, Tang C, McAleer MF, Herman J, Ghia AJ. Time-Driven, Activity-Based Cost Analysis of Radiation Treatment Options for Spinal Metastases. JCO Oncol Pract 16(3):e271-e279, 2020. e-Pub 2019. PMID: 31765268.
- Mesko S, Wang H, Tung S, Wang C, Pasalic D, Ning MS, Pezzi TA, Moreno AC, Reddy JP, Garden AS, Rosenthal DI, Gunn GB, Frank SJ, Fuller CD, Morrison W, Su SY, Hanna E, Phan J. SABR for Skull Base Malignancies: A Systematic Analysis of Set-Up and Positioning Accuracy. Pract Radiat Oncol None(None):None, 2020. e-Pub 2020. PMID: 32240823.
- Kang J, Ning MS, Feng H, Li H, Bahig H, Brooks ED, Welsh JW, Ye R, Miao H, Chang JY. Predicting 5-Year Progression and Survival Outcomes for Early Stage Non-small Cell Lung Cancer Treated with Stereotactic Ablative Radiation Therapy: Development and Validation of Robust Prognostic Nomograms. Int J Radiat Oncol Biol Phys 106(1):90-99, 2020. e-Pub 2019. PMID: 31586665.
- McGovern SL, Wages C, Dimmitt A, Sanders C, Martin D, Ning MS, Manning R, Amin M, Zhu XR, Frank SJ, Gunn GB. Proton Therapy in a Pandemic: An Operational Response to the COVID-19 Crisis. Int J Part Ther 7(1):54-57, 2020. e-Pub 2020. PMID: 33094136.
- Ning MS, Deegan BJ, Ho JC, Chapman BV, Bishop AJ, Allen PK, Tannir NM, Amini B, Briere TM, Wang XA, Tatsui CE, Rhines LD, Brown PD, Li J, Ghia AJ. Low incidence of late failure and toxicity after spine stereotactic radiosurgery: Secondary analysis of phase I/II trials with long-term follow-up. Radiother Oncol 138:80-85, 2019. e-Pub 2019. PMID: 31252298.
- Chapman BV, Swanick CW, Ning MS, Allen PK, Soliman PT, Westin SN, Pardeshi V, Broaddus RR, Lu KH, Jhingran A, Eifel PJ, Klopp AH. Adjuvant combined-modality therapy for stage IIIC endometrioid and non-endometrioid endometrial cancer. Gynecol Oncol 154(1):22-28, 2019. e-Pub 2019. PMID: 31109659.
- Ning MS, Gomez DR, Shah AK, Kim CR, Palmer MB, Thaker NG, Grosshans DR, Liao Z, Chapman BV, Brooks ED, Tang C, Rosenthal DI, Garden AS, Frank SJ, Gunn GB. The Insurance Approval Process for Proton Radiation Therapy: A Significant Barrier to Patient Care. Int J Radiat Oncol Biol Phys 104(4):724-733, 2019. e-Pub 2018. PMID: 30557675.
- Ning MS, Klopp AH, Jhingran A, Lin LL, Eifel PJ, Vedam S, Lawyer AA, Olivieri ND, Guzman AB, Incalcaterra JR, Mesko SM, Pezzi TA, Boyce-Fappiano DR, Shaitelman SF, Frank SJ, Thaker NG. Quantifying institutional resource utilization of adjuvant brachytherapy and intensity-modulated radiation therapy for endometrial cancer via time-driven activity-based costing. Brachytherapy 18(4):445-452, 2019. e-Pub 2019. PMID: 30992185.
- Ning MS, Pinnix CC, Chapman BV, Gunther JR, Milgrom SA, Khoury JD, Jain P, Chen WY, Oriabure ON, Badillo MR, Wang LM, Dabaja BS. Low-dose radiation (4 Gy) with/without concurrent chemotherapy is highly effective for relapsed, refractory mantle cell lymphoma. Blood Adv 3(13):2035-2039, 2019. PMID: 31289030.
- Ning MS, Dean MK, Taylor KA, Arzu I, Fleming ND, Mutyala N, Suresh P, Lewis MA, Tu J, Hassid VJ, Joe T, Byler C, Bloom ES, Shah S. Evaluation and Improvement of Bottlenecking in a Multidisciplinary Oncology Clinic: An Electronic Medical Record Intervention. Cureus 11(5):e4583, 2019. e-Pub 2019. PMID: 31309008.
- Sapienza LG, Ning MS, Jhingran A, Lin LL, Leão CR, da Silva BB, Pellizzon ACA, Gomes MJL, Baiocchi G. Short-course palliative radiation therapy leads to excellent bleeding control: A single centre retrospective study. Clin Transl Radiat Oncol 14:40-46, 2019. e-Pub 2018. PMID: 30555940.
- Kim CR, Kim B, Ning MS, Reddy JP, Liao Z, Tang C, Welsh JW, Mott FE, Shih YT, Gomez DR. Cost Analysis of PET/CT Versus CT as Surveillance for Stage III Non-Small-Cell Lung Cancer After Definitive Radiation Therapy. Clin Lung Cancer 19(4):e517-e528, 2018. e-Pub 2018. PMID: 29685701.
- Ning MS, Ahobila V, Jhingran A, Stecklein SR, Frumovitz M, Schmeler KM, Eifel PJ, Klopp AH. Outcomes and patterns of relapse after definitive radiation therapy for oligometastatic cervical cancer. Gynecol Oncol 148(1):132-138, 2018. e-Pub 2017. PMID: 29089122.
- Ning MS, Tang L, Gomez DR, Xu T, Luo Y, Huo J, Mouhayar E, Liao Z. Incidence and Predictors of Pericardial Effusion After Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 99(1):70-79, 2017. e-Pub 2017. PMID: 28816165.
- Ning MS, Kaminski JM, Pucar D, Shinohara ET. Radiation emergencies: radiation-related brain and lung injury. Journal of Radiation Oncology, 2016. PMID: None.
- Ning MS, Perkins SM, Borinstein SC, Holt GE, Stavas MJ, Shinohara ET. Role of radiation in the treatment of non-metastatic osseous Ewing sarcoma. J Med Imaging Radiat Oncol 60(1):119-28, 2016. e-Pub 2015. PMID: 26439449.
- Johung KL, Yeh N, Desai NB, Williams TM, Lautenschlaeger T, Arvold ND, Ning MS, Attia A, Lovly CM, Goldberg S, Beal K, Yu JB, Kavanagh BD, Chiang VL, Camidge DR, Contessa JN. Extended Survival and Prognostic Factors for Patients With ALK-Rearranged Non-Small-Cell Lung Cancer and Brain Metastasis. J Clin Oncol 34(2):123-9, 2016. e-Pub 2015. PMID: 26438117.
- Stavas MJ, Arneson KO, Ning MS, Attia AA, Phillips SE, Perkins SM, Shinohara ET. The Refusal of Palliative Radiation in Metastatic Non-Small Cell Lung Cancer and Its Prognostic Implications. J Pain Symptom Manage 49(6):1081-1087.e4, 2015. e-Pub 2015. PMID: 25596010.
- Ning MS, Perkins SM, Dewees T, Shinohara ET. Evidence of high mortality in long term survivors of childhood medulloblastoma. J Neurooncol 122(2):321-7, 2015. e-Pub 2015. PMID: 25557108.
- Ning MS, Kim AS, Prasad N, Levy SE, Zhang H, Andl T. Characterization of the Merkel Cell Carcinoma miRNome. J Skin Cancer 2014:289548, 2014. e-Pub 2014. PMID: 24627810.
- Stavas MJ, Shinohara ET, Attia A, Ning MS, Friedman JM, Cmelak AJ. Short course high dose radiotherapy in the treatment of anaplastic thyroid carcinoma. J Thyroid Res 2014:764281, 2014. e-Pub 2014. PMID: 25379320.
- Ning MS, Price SE, Ta JA, Davies KM. Nucleophilic reactivity of thiolate, hydroxide and phenolate ions towards a model O-arylated diazeniumdiolate prodrug in aqueous and cationic surfactant media. J Phys Org Chem 23(3):220-226, 2010. PMID: 21533014.
Other Articles
- Li H, Hu X, Ning MS, Fuller GN, Stewart JM, Gilliam JC, Wu J, Le X, Vaporciyan AA, Lee JJ, Gibbons DL, Heymach JV, Futreal A, Zhang J Case report: Molecular profiling facilitates the diagnosis of a challenging case of lung cancer with choriocarcinoma features. Front Oncol 14:1324057, 2024. PMID: 38590653.
- Sezen D, Verma V, He K, Abana CO, Barsoumian H, Ning MS, Tang C, Hurmuz P, Puebla-Osorio N, Chen D, Tendler I, Comeaux N, Nguyen QN, Chang JY, Welsh JW Considerations for Clinical Trials Testing Radiotherapy Combined With Immunotherapy for Metastatic Disease. Semin Radiat Oncol 31(3):217-226, 2021. PMID: 34090648.
- Patel RR, Verma V, Barsoumian H, Ning MS, Chun SG, Tang C, Chang JY, Lee PP, Gandhi S, Balter P, Dunn JD, Chen D, Puebla-Osorio N, Cortez AM, Welsh JW Use of Multi-Site Radiation Therapy as Systemic Therapy: A New Treatment Approach Personalized by Patient Immune Status. Int J Radiat Oncol Biol Phys 109(2):352-364, 2020. PMID: 32798606.
- Ng SSW, Ning MS, Lee P, McMahon RA, Siva S, Chuong MD Single-Fraction Stereotactic Body Radiation Therapy: A Paradigm During the Coronavirus Disease 2019 (COVID-19) Pandemic and Beyond?. Adv Radiat Oncol 5(4):761-773, 2020. PMID: 32775790.
- McGinnis GJ, Ning MS, Nitsch PL, O'Reilly MS, McAleer MF, Koong AC, Chang JY Rapid Detection of Asymptomatic Coronavirus Disease 2019 by Computed Tomography Image Guidance for Stereotactic Ablative Radiotherapy. J Thorac Oncol 15(6):1085-1087, 2020. PMID: 32311499.
- Samson P, Ning MS, Shaverdian N, Shepherd AF, Gomez DR, McGinnis GJ, Nitsch PL, Chmura S, O'Reilly MS, Lee P, Chang JY, Robinson C, Lin SH Clinical and Radiographic Presentations of COVID-19 among Patients Receiving Radiation Therapy for Thoracic Malignancies. Adv Radiat Oncol None(None):None, 2020. PMID: 32395673.
- Lin LL, Lakomy DS, Ning MS, Simpkins F, Jhingran A Combining novel agents with radiotherapy for gynecologic malignancies: beyond the era of cisplatin. Int J Gynecol Cancer 30(4):409-423, 2020. PMID: 32193219.
- Sapienza LG, Salcedo MP, Ning MS, Jhingran A, Klopp AH, Calsavara VF, Schmeler KM, Leite Gomes MJ, de Freitas Carvalho E, Baiocchi G Pelvic Insufficiency Fractures After External Beam Radiation Therapy for Gynecologic Cancers: A Meta-analysis and Meta-regression of 3929 Patients. Int J Radiat Oncol Biol Phys 106(3):475-484, 2020. PMID: 31580930.
- Smith GL, Lopez-Olivo MA, Advani PG, Ning MS, Geng Y, Giordano SH, Volk RJ Financial Burdens of Cancer Treatment: A Systematic Review of Risk Factors and Outcomes. J Natl Compr Canc Netw 17(10):1184-1192, 2019. PMID: 31590147.
- Sapienza LG, Ning MS, Pellizzon ACA, Jhingran A, Klopp AH, Lin LL, Kollmeier MA, Calsavara VF, Gutierrez NDS, Chojniak R, Gomes MJL, Baiocchi G Detection of air gaps around the cylinder by postinsertion computed tomography in vaginal cuff brachytherapy: A prospective series, systematic review, and meta-analysis. Brachytherapy 18(5):620-626, 2019. PMID: 31160198.
- Brooks ED, Ning MS, Verma V, Zhu XR, Chang JY Proton therapy for non-small cell lung cancer: the road ahead. Transl Lung Cancer Res 8(Suppl 2):S202-S212, 2019. PMID: 31673525.
- Sapienza LG, Ning MS, Taguchi S, Calsavara VF, Pellizzon ACA, Gomes MJL, Kowalski LP, Baiocchi G Altered-fractionation radiotherapy improves local control in early-stage glottic carcinoma: A systematic review and meta-analysis of 1762 patients. Oral Oncol 93:8-14, 2019. PMID: 31109700.
- Ning MS, Gomez DR, Heymach JV, Swisher SG Stereotactic ablative body radiation for oligometastatic and oligoprogressive disease. Transl Lung Cancer Res 8(1):97-106, 2019. PMID: 30788239.
- Ning MS, Andl T Concise review: custodians of the transcriptome: how microRNAs guard stemness in squamous epithelia. Stem Cells 33(4):1047-54, 2015. PMID: 25524325.
- Ning MS, Dahir KM, Castellanos EH, McGirt LY Sodium thiosulfate in the treatment of non-uremic calciphylaxis. J Dermatol 40(8):649-52, 2013. PMID: 23663061.
- Ning MS, Andl T Control by a hair's breadth: the role of microRNAs in the skin. Cell Mol Life Sci 70(7):1149-69, 2013. PMID: 22983383.
Book Chapters
- He, K, Selek, U, Barsoumian, H, Sezen, D, Ning, M, Puebla-Osorio, N, Schoenhals, JE, Chen, D, Leuschner, C, Cortez, MA, Welsh, J. Mechanisms of Action of Radiotherapy and Immunotherapy in Lung Cancer: Implications for Clinical Practice. In: Advances in Radiation Oncology in Lung Cancer. Springer, 399-414, 2023.
- Ning, M, Verma, V, Lin, SH. Thoracic Malignancies: Proton Beam and Carbon‐ion Therapy for Thoracic Cancers and Recurrent Disease. In: Principles and Practice of Particle Therapy. Wiley, 261-285, 2022.
- Yoder AK, Ning MS, Joyner MM, Lin LL. Cancer Radiotherapy: General Considerations and Human Radiobiology. In: Locoregional Radionuclide Cancer Therapy: Clinical and Scientific Aspects. None. Springer, 2021.
Selected Presentations & Talks
Local Presentations
- 2024. Insurance Automation Workflows in Radiation Oncology. Invited. Procedures and Therapeutics Division Semi-Annual Operational Retreat. Houston, Texas, US.
- 2019. Enhancing the Value of Radiation Therapy: Novel Indications, Better Outcomes, and Lower Costs (Grand Rounds). Invited. Houston, Texas, US.
- 2019. The Insurance Approval Process for Proton Radiation Therapy: A Significant Barrier to Patient Care with Coverage Gaps for Vulnerable Populations (Oral Presentation Competition in Population Science Research). Conference. Bristol-Myers Squibb. Houston, Texas, US.
- 2019. Operations Management in Radiation Oncology: Standardizing Radiation Treatment Scheduling Timelines Using a Data-Driven Tier System (Seminar Lecture). Invited. Houston, Texas, US.
National Presentations
- 2024. Cost-Effectiveness of Proton Beam Therapy for H&N Cancer. Invited. National Association for Proton Therapy (NAPT) 2024 Annual Meeting. Boston, Massachusetts, US.
- 2023. Financial and Profitability Analysis of Clinical Trial Patients. Invited. MD Anderson Cancer Network Meeting (at ASTRO 2023). San Diego, California, US.
- 2023. Proton Therapy for Thoracic Malignancies: Novel Indications and Trends. Invited. Banner Health Thoracic Multidisciplinary Operations Meeting, US.
- 2022. Challenging NSCLC Cases: Central, Ultracentral, and Reirradiation. Invited. American Society for Radiation Oncology (ASTRO) 2022 Conference. San Antonio, Texas, US.
- 2021. Independent Review Organization (IRO) Insurance Appeal Analysis. Invited. Insurance Authorization Webinar, US.
- 2021. Proton Therapy Training Seminar: Liver and Thoracic Sites. Invited, US.
- 2021. LA-NSCLC: Definitive, Adjuvant, and Salvage Radiation Therapy. Invited. LA-NSCLC: Definitive, Adjuvant, and Salvage Radiation Therapy, CA, US.
- 2020. Proton Therapy for Thoracic Malignancies: Non-Small Cell Lung Cancer. Invited, OK, US.
- 2020. Improving Patient Access to Proton Therapy through Stakeholder Collaboration: Three-Year Outcomes of a Prospective Statewide Insurance Coverage Pilot with a Self-Funded Employer Plan (Webinar). Invited. Washington, DC, US.
- 2019. Predictors of Mid-Treatment Mortality for Patients Undergoing Palliative Radiation Therapy: Improving the Quality of End-of-Life Care. Conference. Predictors of Mid-Treatment Mortality for Patients Undergoing Palliative Radiation Therapy: Improving the Quality of End-of-Life Care. Chicago, IL, US.
- 2019. Operations Management in Radiation Oncology: Standardizing Radiation Treatment Scheduling Timelines Using a Data-Driven Tier System. Conference. Operations Management in Radiation Oncology: Standardizing Radiation Treatment Scheduling Timelines Using a Data-Driven Tier System. Chicago, IL, US.
- 2018. Cervical Contouring and Inoperable Endometrial Cases. Conference. Cervical Contouring and Inoperable Endometrial Cases. Houston, TX, US.
- 2018. Quantifying institutional resource utilization of adjuvant brachy and IMRT for endometrial cancer via time-driven activity-based costing. Conference. Quantifying institutional resource utilization of adjuvant brachy and IMRT for endometrial cancer via time-driven activity-based costing. San Francisco, CA, US.
- 2017. Outcomes and Patterns of Relapse after Definitive Radiation Therapy for Oligometastatic Cervical Cancer. Conference. Outcomes and Patterns of Relapse after Definitive Radiation Therapy for Oligometastatic Cervical Cancer. San Diego, CA, US.
Grant & Contract Support
| Title: | Establishing the value of proton therapy for head and neck cancer: Assessing cost-effectiveness, comparative effectiveness, and financial toxicity of therapy |
| Funding Source: | National Assocation for Proton Therapy (NAPT) Health Economics Research Initiative (HERI) |
| Role: | Co-I |
Patient Reviews
CV information above last modified February 07, 2025